Patient perspectives on simultaneous methotrexate-folic acid intake to improve adherence in rheumatoid arthritis: a cross-sectional survey

Clicks: 24
ID: 331789
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #41 of 143 articles by views in Rheumatology Advances in Practice

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 143 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Objective To assess real-world adherence to folic acid supplementation with methotrexate and patient perceptions of a simplified, same-day dosing strategy in rheumatoid arthritis. Methods We conducted a cross-sectional online survey co-designed with patient representatives and distributed by the French patient association AFPric. Rheumatoid arthritis patients treated with methotrexate were eligible. The questionnaire captured methotrexate and folic acid regimens, omissions, adverse events, and attitudes toward same-day methotrexate and folic acid administration. Analyses were descriptive with prespecified subgroup comparisons. Results Among 967 respondents (86.8% women; mean age 62.4 years), 86.7% reported once-weekly folic acid supplementation. Overall, 25.5% reported at least occasional folic acid omission, with omissions more frequent among long-term methotrexate users. Nausea after methotrexate was reported by 46.6% of respondents and by 52.6% of those reporting folic acid omissions. A same-day methotrexate and folic acid regimen was perceived as simpler by 30.5%, while 41.5% believed it could reduce folic acid omission. Overall, 64.8% indicated that they would be willing to participate in a randomised controlled trial evaluating simultaneous administration. Conclusion One in four people with rheumatoid arthritis treated with methotrexate reported folic acid omissions. Many respondents believed that a same-day regimen could reduce folic acid omissions, and interest in participating in a clinical trial was high. These findings support the feasibility of prospectively evaluating whether same-day methotrexate and folic acid administration may improve adherence and tolerability in selected patients, particularly those receiving once-weekly folic acid supplementation, without compromising methotrexate effectiveness.
Reference Key
openalex_W7221023289 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Elisa Dalix, Naïma Hamamouche, Irène Pico Philippe, Sandrine Rollot, Hubert Marotte
Are you one of these authors? Claim your profile
Journal Rheumatology Advances in Practice
Year 2026
DOI
10.1093/rap/rkag109
URL
https://doi.org/10.1093/rap/rkag109
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.